MALIGNANT PLEURAL MESOTHELIOMA: A CHANGING

MALIGNANT PLEURAL MESOTHELIOMA: A CHANGING

Program
MALIGNANT PLEURAL MESOTHELIOMA: A CHANGING PARADIGM OF CARE
27-28 May 2011
Reşat Kaynar Oditorium, Marmara University Medical Faculty, Istanbul, Turkey
Participants
1. Rengin Ahıskalı, MD, Patoloji AD, Marmara Üniversitesi Hastanesi, İstanbul, Türkiye
2. Vincenzo Ambrogi, MD, Cerrahi AD, Tor Vergata University, Rome, Italy
3. Hasan F.Batırel, MD, PhD, Göğüs Cerrahisi AD, Marmara Üniversitesi Hastanesi,
İstanbul, Türkiye
4. Raphael Bueno, MD, Göğüs Cerrahisi Bilim Dalı, Brigham and Women’s Hospital,
Harvard Medical School, Boston, USA
5. Hale Başak Özkök, MD, Radyasyon Onkolojisi AD, Acıbadem Üniversitesi, İstanbul,
Türkiye
6. Lucian R. Chirieac, Patoloji AD, Brigham and Women’s Hospital, Harvard Medical
School, Boston, USA
1/6
Program
7. Muzaffer Metintaş, MD, Göğüs Hastalıkları AD, Osmangazi Üniversitesi Hastanesi,
Eskişehir, Türkiye
8. Selma Metintaş, MD, Halk Sağlığı AD, Osmangazi Üniversitesi Hastanesi, Eskişehir,
Türkiye
9. Kazunori Okabe, MD, Göğüs Cerrahisi Bilim dalı, Yamaguchi Ube Medical Center,
Yamaguchi, Japan
10. Isabelle Opitz, MD, Göğüs Cerrahisi Bilim Dalı, Zürih Üniversitesi Hastanesi, Zürih,
İsviçre
11. William G. Richards, PhD, Göğüs Cerrahisi Bilim Dalı, Brigham and Women’s Hospital,
Harvard Medical School, Boston, USA
12. Abdurrahman Şenyigit, MD, Göğüs Hastalıkları AD, Dicle Üniversitesi Hastanesi,
Diyarbakır, Türkiye
13. David J.Sugarbaker, MD, Göğüs Cerrahisi Bilim Dalı, Brigham and Women’s Hospital,
Harvard Medical School, Boston, USA
14. Alper Toker, MD, Göğüs Cerrahisi AD, İstanbul Üniversitesi İstanbul Tıp Fakültesi,
İstanbul, Türkiye
15. Serdar Turhal, MD, Tıbbi Onkoloji Bilim Dalı, Dahiliye Anabilim Dalı, Marmara
Üniversitesi Hastanesi, İstanbul, Türkiye
16. Walter Weder, MD, Göğüs Cerrahisi Bilim Dalı, Zürih Üniversitesi Hastanesi, Zürih,
2/6
Program
İsviçre
17. Fulden Yumuk, MD, Tıbbi Onkoloji Bilim Dalı, Dahiliye Anabilim Dalı, Marmara
Üniversitesi Hastanesi, İstanbul, Türkiye
A total of 80 participants attendeed in meeting.
Symposium Program
28 MAY 2011
08:05-08:30 Registration and Breakfast
08:30-08:40 Symposium Opening David J. Sugarbaker, Hasan F.
Batırel
SESSION 11: EPIDEMILOGY - CLINIC
Head: Selma Metintaş - Rengin Ahıskalı
08:40-09:00 Epidemiology of Mesothelioma ……………… Muzaffer Metintaş
3/6
Program
09:00-09:20 Examination of patients in clinic……………..Abdurrahman Şenyiğit
09:20-09:40 Asbestos fibers and moleculary pathogensis of malignancy…………..Kazunori
Okabe
09:40-10:00 Problems in the pathological diagnosis of mesothelioma…………….Lucian R.
Chirieac
10:00-10:30 Cofffee
SESSION 2: RECOGNIZE THE MESOTHELIOMA
Head: Isabelle Opitz - Fulden Yumuk 10:30-11:00 New staging options……………….William G. Richards
11:00-11.30 Genomics: Role in the planning of diagnosis and treatment ….Raphael Bueno 11:30-12:00 Surgical techniques in mesothelioma…………………..David J. Sugarbaker
12:00-13:00 Lunch
SESSION: TEDAVİ SEÇENEKLERİ: UZUN DÖNEM SAĞKALIM İÇİN ÜMİT
4/6
Program
Head: Alper Toker - Hasan Batırel
13:00-13:30 Intraoperative heated chemotherapy: Technique and choosing patient….
David J.
Sugarbaker
13:30-14:00 Neoadjuant chemotherapy and EPP………………Walter Weder
14:00-14:30 Long term prognosis…………….David J. Sugarbaker
14:30-15:00 Coffee
SESSION 4: MULTIMODALITY TREATMENT and SURVIVAL
Head: Serdar Turhal - Muzaffer Metintaş
15:00-15.20 New techniques in radiotherapy……………….Hale Başak Özkök
15:20-15:40 Chemothrapy: which drugs ? When ?..................Fulden Yumuk
15:40-16:00 Trimodality treatment………………..Hasan F. Batırel 16:00-16:20 Life qualty for patients treated by surgical techniques………..Vincenzo
Ambrogi
5/6
Program
16:20-16:40 Discussion and Closing ……………………………Hasan F.Batırel - David J
Sugarbaker
6/6